Cellular FLICE-inhibitory protein (c-FLIP) is an inhibitor of caspase-8 and is required for macrophage survival. Recent studies have revealed a selective role of caspase-8 in noncanonical IL-1b production that is independent of caspase-1 or inflammasome. Here we demonstrated that c-FLIP L is an unexpected contributor to canonical inflammasome activation for the generation of caspase-1 and active IL-1b. Hemizygotic deletion of c-FLIP impaired ATP-and monosodium uric acid (MSU)-induced IL-1b production in macrophages primed through Toll-like receptors (TLRs). Decreased IL-1b expression was attributed to a reduced activation of caspase-1 in c-FLIP hemizygotic cells. In contrast, the production of TNF-a was not affected by downregulation in c-FLIP. c-FLIP L interacted with NLRP3 or procaspase-1. c-FLIP is required for the full NLRP3 inflammasome assembly and NLRP3 mitochondrial localization, and c-FLIP is associated with NLRP3 inflammasome. c-FLIP downregulation also reduced AIM2 inflammasome activation. In contrast, c-FLIP inhibited SMAC mimetic-, FasL-, or Dectin-1-induced IL-1b generation that is caspase-8-mediated. Our results demonstrate a prominent role of c-FLIP L in the optimal activation of the NLRP3 and AIM2 inflammasomes, and suggest that c-FLIP could be a valid target for treatment of inflammatory diseases caused by overactivation of inflammasomes.
Death receptors initiate apoptotic signals through the formation of death-inducing signaling complexes (DISCs) containing FADD and procaspase-8. Cellular FLICE-inhibitory protein (c-FLIP) inhibits death receptor-induced apoptosis by blocking the activation of caspase-8 at DISC. [1] [2] [3] [4] [5] c-FLIP is expressed in 3 isoforms: long form (c-FLIP L ), short form (c-FLIP S ), and Raji form (c-FLIP R ). All three c-FLIP isoforms contain two death effector domains (DEDs), and their competition with procaspase-8 for FADD binding inhibits caspase-8 activation. c-FLIP L possesses an additional caspase-like domain (CLD) at its C terminus and, when present at low levels, may also promote caspase-8 activation. c-FLIP deficiency profoundly increases sensitivity to death receptor-mediated apoptosis. [6] [7] [8] In addition to its prominent anti-apoptotic activity, c-FLIP is essential for embryonic development and T-cell development. 6, 8 c-FLIP is also required for the development of macrophages. 9 The inflammasome is assembled in macrophages and monocytes by inflammatory stimuli to process procaspase-1 into active caspase-1 and to generate mature IL-1b and IL-18. [10] [11] [12] [13] [14] Different types of inflammasomes are activated in response to specific ligands or pathogens. For the AIM2 inflammasome, its activation is initiated by the binding of cytosolic dsDNA to AIM2. For NLRP3 inflammasomes, their assembly is activated by a wide variety of ligands such as microbes, microbial products, toxins, or aggregated particles. The formation of the NLRP3 inflammasome involves two sequential stages. In the first stage, signals from TLRs or other innate receptors activate NF-kB, leading to enhanced expression of pro-IL-1b and NLRP3. 15 In the second stage, a distinct signal stimulates the binding of NLRP3 to ASC and procaspase-1. Cytosolic K þ reduction, reactive oxygen species, and lysosomal protease cathepsin B have been suggested as potential second signals for NLRP3 inflammasome formation, but the exact biochemical processes involved in inflammasome assembly remain incompletely understood. [10] [11] [12] 14 Recent studies reveal that caspase-8 regulates specific inflammasome activation and IL-1b generation. Ligation of TLR3 and TLR4 has been shown to promote the processing of pro-IL-1b by caspase-8, independent of caspase-1 and NLRP3. 16 Engagement of Dectin-1 induces activation of the noncanonical caspase-8 inflammasome, leading to caspase-1-independent generation of active IL-1b. 17 Depletion of inhibitors of apoptosis protein (IAPs) by a SMAC mimetic in TLR-stimulated myeloid cells triggers the cleavage of IL-1b by 1 caspase-8, in addition to activation of the canonical NLRP3-caspase-1 pathway. 18 Stimulation of Fas also generates IL-1b in TLR-primed myeloid cells by the noncanonical caspase-8 pathway that is independent of ASC and caspase-1. 19 In contrast, caspase-8 has been shown to inhibit NLRP3 inflammasome activation in the epidermis. 20 A more recent study illustrates that caspase-8 does not affect conventional two-signal-induced NLRP3 inflammasome assembly, but suppresses NLRP3 inflammasome activated by LPS alone through blocking RIPK3-dependent processes. 21 In the present study, we demonstrated that c-FLIP is required for optimal canonical NLRP3 and AIM2 inflammasome activation. Downregulation of c-FLIP impaired caspase-1 activation and IL-1b production. We found a specific interaction between c-FLIP L and NLRP3/procaspase-1/AIM2. In contrast, c-FLIP suppressed SMAC mimetic-induced and caspase-8-dependent IL-1b generation. Our results indicate a novel function of c-FLIP by which c-FLIP promotes the assembly of NLRP3 and AIM2 inflammasomes, and suggest that c-FLIP could be a target for treating auto-inflammatory diseases. Figure 1) . Treatment of PMA-primed THP-1 cells with NLRP3 inflammasome activators including R837, monosodium urate (MSU), R848, Pam3CSK4, or heat-killed Listeria monocytogenes (HKLM) led to IL-1b secretion (Figure 1b) . The generation of IL-1b was attributed to the appearance of the cleaved caspase-1 and p17 IL-1b in cell supernatant (SUP) from stimulated THP-1 cells (Figures 1d-f) . Pro-IL-1b was present in total-cell lysates (TCL) from PMA-primed THP-1 cells, and was further upregulated by treatment with Pam3CSK4 or HKLM, but not MSU (Figures 1d-f) . The failure of MSU, alum crystals, or nigericin to upregulate pro-IL-1b in THP-1 cells is likely due to their inability to activate NF-kB (data not shown). Notably, Pam3CSK4 and HKLM also stimulated the expression of c-FLIP proteins (Figures 1e and f), which could be attributed to an induction of Cflar transcript by TLR (Supplementary Figure 2a) . c-FLIP knockdown significantly reduced the secretion of IL-1b (Figure 1b) . Pro-IL-1b induction was comparable between control and c-FLIP-deficient THP-1 cells stimulated by Pam3Csk4 or HKLM (Figures 1e-f) . In contrast, the decrease in IL-1b production was associated with a diminished activation of caspase-1 following these treatments (Figures 1d-f) , Control and c-FLIP-knocked down THP-1 cells were treated with PMA (500 ng/ml) for 3 h, cultured overnight, and then stimulated with R837 (10 mg/ml), MSU (150 mg/ml), R848 (2 mg/ml), Pam3CSK4 (Pam, 0.5 mg/ml), or HKLM (3 Â 10 8 /ml) 5 h. The secreted IL-1b (b) and TNF-a (c) in supernatants were determined by ELISA. (d-f) c-FLIP deficiency decreased procaspase-1 processing and IL-1b generation. Cell supernatants in (b) were precipitated with cold ( À 20 1C) acetone. Cells from (b) were also harvested and cell lysates prepared. Supernatant precipitates (SUP) and total cell lysates (TCL) were resolved on SDS-PAGE, and the expression of p17 IL-1b, procaspase-1, active p10 caspase-1, c-FLIP L , and pro-IL-1b determined. Error bars indicates S.D. of a specific experiment. **Po0.01, ***Po0.001 for paired t-test. All experiments (b-f) were repeated three times with similar results suggesting an impaired NLRP3 inflammasome function. As another control, TNF-a production was nearly identical between control and c-FLIP-knocked down THP-1 cells induced by R848, Pam3CSK4, or HKLM (Figure 1c) . These results suggest that c-FLIP is required for the full activation of the NLRP3 inflammasome in THP-1 cells.
c-FLIP hemizygotic deficiency impairs NLRP3 inflammasome activation in normal macrophages and dendritic cells. We next examined the effect of c-FLIPknockout on the activation of NLRP3 inflammasome in macrophages. As previously reported, c-FLIP-knockout led to defective survival of macrophages, 9, 22 and thioglycollateelicited peritoneal macrophages were absent in c-FLIP
Cre mice (data not shown). Bone marrow cells from c-FLIP f/f LysM Cre mice differentiated into macrophages after 6-day culturing in vitro were in numbers less than the control (c-FLIP f/f ) bone marrow-derived macrophages (BMDMs). Consistent with previous analysis that the floxed Cflar allele is incompletely deleted in the surviving macrophages, Figure 3b) . We first examined whether decreased IL-1b production was due to reduced cell survival in c-FLIP þ / À BMDMs. Supplementary Figure 4 demonstrates that cell viability was not compromised in c-FLIP hemizygous macrophages before or after NLRP3 inflammasome stimulation. In addition, similar amounts of TNF-a were produced by control and c-FLIP þ / À macrophages activated by LPS, R848, and Pam3CSK (Figure 2d, Supplementary  Figure 3d) . Furthermore, the induction of pro-IL-1b and NLRP3 proteins was comparable between control and c-FLIP hemizygotic BMDMs treated with LPS (Figures 2e and f, Supplementary Figures 3e and f) . In addition, LPSstimulated similar levels of Il1b and Nlrp3 transcripts in control and Cflar-deficient macrophages ( Supplementary  Figures 2b and c) . We also evaluated the activation of NF-kB, essential for the expression of Il1b and Nlrp3, in Cflar þ / À macrophages. LPS-induced RelA (p65) nuclear translocation was nearly identical between control and c-FLIP c-FLIP is required for the activity of the reconstituted NLRP3 inflammasome. We also studied the requirement of c-FLIP for NLRP3 inflammasome reconstituted in 293T cells. c-FLIP was effectively knocked down in 293T cells by specific shRNA (Figure 4a ). 293T cells do not express procaspase-1, NLRP3, or ASC, and introduction of these components could be readily detected (Figure 4b ). Mature IL-1b was only generated in 293T cells with simultaneous reconstitution of pro-IL-1b, ASC, procaspase-1, and NLRP3 as measured by immunoblots and ELISA (Figures 4b and c) . Knockdown of c-FLIP reduced the secretion of p17 IL-1b protein in 293T cells (Figures 4b and c) . Therefore, c-FLIP is required for the activation of NLRP3 inflammasome reconstituted in 293T cells.
Interaction of c-FLIP with NLRP3 and procaspase-1. As the enhancing effect of c-FLIP on IL-1 production was mainly on caspase-1 processing, we examined the potential interaction of c-FLIP with components of the inflammasomes. Figure 9b) . A similar role of c-FLIP was found in ASC speck formation, 24 another indicator of pyroptosome formation. In control THP-1 cells, treatment with nigericin led to a significant formation of ASC specks (Supplementary Figure 10) . c-FLIP knockdown impaired the formation of ASC specks in THP-1. Therefore, c-FLIP deficiency prevents ASC oligomerization and decreases pyroptosome formation.
We also used in situ proximity ligation assay 25 to measure the formation of inflammasomes in macrophages. The association of NLRP3 and procaspase-1 was undetectable in wild-type macrophages before and after LPS stimulation (Figure 6a) , and the NLRP3-procaspase-1 interaction was visible only after adding ATP to LPS-primed macrophages (Figure 6a) . A similar colocalization between NLRP3 and ASC was observed in macrophages treated with both LPS and ATP (Figure 6b ). c-FLIP hemizygotic deficiency profoundly decreased the NLRP3-procaspase-1 association and NLRP3-ASC interaction in macrophages treated with LPS and ATP (Figures 6a and b) . Recent studies have also revealed that inflammasome activation involves the mitochondrial localization of NLRP3. 26, 27 Figure 6c illustrates that nigercin promoted the colocalization of NLRP3 with Mitotracker, 26 which was substantially decreased in c-FLIPknocked down cells. These results suggest that c-FLIP is required for the full interaction of NLRP3-caspase-1 and NLRP3-ASC, as well as the situation of NLRP3 in mitochondria, during inflammasome assembly.
We further determined the association of c-FLIP with NLRP3 in macrophages after inflammasome formed. In situ proximity ligation assay revealed that close approximation of c-FLIP with NLRP3 was induced by the dual signals that promote inflammasome assembly ( Supplementary  Figure 11c) . In a different analysis, the interaction between c-FLIP and NLRP3 could be detected by immunoprecipitation in BMDMs treated with LPS and nigericin (Supplementary Figure 11a) . We further examined the association between NLRP3 and c-FLIP in inflammasome activation in vitro. c-FLIP hemizygotic deficiency increases SMAC mimetic-, FasL, or Dectin-1-induced IL-1b generation. Depletion of IAPs by genetic manipulation or a SMAC mimetic in TLRprimed macrophages triggers the cleavage of IL-1b by caspase-8, in addition to the canonical NLRP3-caspase-1 pathway. 18 We also examined the role of c-FLIP in SMAC mimetic-induced IL-1b production, because c-FLIP specifically suppresses caspase-8 activity. In wild-type macrophages primed with LPS, the SMAC mimetic AT-406 induced modest IL-1b secretion (Figure 8a) . A large portion of IL-1b processing induced by LPS and AT-406 was mediated by caspase-8, as shown by their sensitivity to z-IETD inhibition (Figure 8b ). In contrast, IL-1b production stimulated by LPS plus ATP in BMDMs was not affected by z-IETD (data not shown), consistent with recent report that caspase-8 is not involved in conventional NLRP3 inflammasome activation. 21 c-FLIP hemizygotic deletion enhanced the production of IL-1b (Figures 8a and b) . Similar to a previous report, 18 AT-406 treatment generated both caspase-1 and caspase-8 (Figure 8c ). c-FLIP hemizyogotic deficiency increased the processing of procaspase-8, but did not affect the cleavage of procaspase-1. Consequently, more p17 IL-1b was generated in c-FLIP þ / À macrophages activated by LPS and AT-406 (Figure 8c) .
We further determined the regulatory role of c-FLIP in FasL-induced and caspase-8-dependent IL-1b production. Figure 12b) . We also examined Dectin-1-mediated and caspase-8-dependent IL-1b generation 17 in c-FLIP hemizygotic macrophages. Heat-killed Candida albicans (HKCA)-induced IL-1b production was inhibited by z-IETD, confirming the involvement of caspase-8 (Supplementary Figure 12c) . Dectin-1-mediated IL-1b secretion was enhanced by more than threefold in FLIP f/f
LysM
Cre BMDMs, relative to FLIP f/f BMDMs. Therefore, c-FLIP has an inhibitory role in IAP inhibitor-, FasL-, or HKCA-triggered IL-1b secretion, in contrast to the stimulatory role of c-FLIP in the NLRP3 inflammasome and AIM2 inflammasome. 
Discussion
The assembly of the inflammasome is essential for the processing of procaspase-1 and pro-IL-1b. With the exception of the NLRP1 inflammasome, 29 the detailed biochemical processes in the assembly of the inflammasome remain largely unclear. In the present study we identify a novel role of c-FLIP in the full activation of NLRP3 and AIM2 inflammasome. c-FLIP hemizygotic deficiency impaired procaspase-1 cleavage and IL-1b maturation, whereas c-FLIP overexpression enhanced caspase-1 processing and IL-1b production (Figures 1-3, Supplementary Figures 3 and 6) . We also demonstrated that the formation of inflammasome in situ was diminished in the absence of c-FLIP (Figure 6 ). c-FLIP L interacts with NLRP3 and procaspase-1 when co-expressed ( Figure 5 ). In addition, we observed a close association of c-FLIP with NLRP3 during inflammasome assembly (Supplementary Figure 11) . c-FLIP is an inhibitor of death receptor-mediated apoptosis and necrosis. 1, 30, 31 Complete deletion of c-FLIP leads to significant death of macrophages. 9, 22 We measured cell death before or after inflammasome activation but did not find any increase in cell death in c-FLIP þ / À macrophages (Supplementary Figure 1 and 4) . In addition, we did not find that c-FLIP downregulation had any effect on the production of TNF-a (Figures 1 and 2, Supplementary Figures 3 and 6) . Furthermore, hemizygous c-FLIP deficiency decreased NLRP3-and AIM2-mediated IL-1b generation (Figures 2 and 7) , but increased AT-406-and FasL-triggered IL-1b secretion in BMDMs (Figure 8, Supplementary Figure 12) . Therefore, the diminished activation of NLRP3 and AIM2 inflammasomes in c-FLIP-downregulated macrophages was not due to reduced survival of macrophages. c-FLIP has been shown to activate NF-kB, 32, 33 which is required for the transcription of pro-IL-1b and NLRP3, suggesting a possibility that the observed reduction in IL-1b secretion is due to attenuated expression of pro-IL-1b and NLRP3. We found normal NF-kB activation in c-FLIP Figure 3d and Figure 6d) . Therefore, c-FLIP is not essential for TLR-induced NF-kB activation in macrophages.
We also found that c-FLIP is upregulated by inflammatory stimuli including LPS, Pam3CSK4, and HKLM in wild-type macrophages (Figure 1, Supplementary Figures 2a, 3e, and  3f) . NF-kB activation represents a common signaling process downstream of various TLRs, while c-FLIP is a well-known target transactivated by NF-kB. Therefore, the first stage of inflammasome activation involves the induction of c-FLIP, in addition to the upregulation of pro-IL-1b and NLRP3. Our results thus suggest a possibility that that TLR-induced increase in c-FLIP expression ensures that there are sufficient amounts of c-FLIP to assist during the assembly of the inflammasome that will then promote the generation of active caspase-1.
A recent study revealed that caspase-8 deficiency leads to skin inflammation, caused by increased inflammasome formation and IL-1b production. 20 c-FLIP, by itself a caspase-8 inhibitor, may exert its function through this inhibition. However, the enhanced inflammasome formation in caspase-8-null epidermal cells is attributed to increased expression of NLRP3, 20 yet there was no change in NLRP3 levels in c-FLIP-overexpressing or c-FLIP-knocked down macrophages (Figures 1-3) , suggesting a difference between epidermal cells and macrophages. In a more recent study, caspase-8 deficiency sensitized dendritic cells to produce IL-1b by stimulation with LPS alone, but caspase-8 is not involved in NLRP3 inflammasome activation induced by both LPS and ATP. 21 The participation of c-FLIP in NLRP3 and AIM2 inflammasome activation reported in this study is thus unlikely mediated by inhibition of caspase-8 activity. In addition, we examined the role of c-FLIP in caspase-8-dependent inflammasome activation stimulated by SMAC mimetic, Dectin-1, or FasL, [17] [18] [19] and found that c-FLIP suppressed IL-1b generation by inhibition of caspase-8 ( Figure 8, Supplementary Figure 12) , demonstrating opposing functions of c-FLIP in NLRP3/AIM2 and caspase-8-dependent inflammasome activation.
Our results illustrating that c-FLIP is required for the activation of both the NLRP3 inflammasome and AIM2 inflammasome suggest that c-FLIP may act at a stage common to the activation of different inflammasomes. c-FLIP inhibits autophagy, 31, 34 and autophagy has been shown to inhibit inflammasome formation. [35] [36] [37] Therefore, it is possible that the inhibition of autophagy by c-FLIP is required for the activation of the inflammasome. Notably, we found that c-FLIP L interacted with NLRP3/procaspase-1. c-FLIP S , the c-FLIP isoform that does not bind NLRP3/procaspase-1 ( Figure 5 ), did not promote inflammasome activation (Figure 3 ). In addition, we identified that c-FLIP L is part of NLRP3 inflammasome formed in vivo and in vitro (Supplementary Figure 11) . Future work will help identify the exact mechanism orchestrating c-FLIP-assisted inflammasome formation.
Aberrant NLRP3 inflammasome activation contributes to auto-inflammatory diseases as well as inflammasomeassociated diseases including gout, silicosis, asbestosis, atherosclerosis, Alzheimer's disease, and type 2 diabetes mellitus. 38, 39 A number of anti-inflammatory molecules have been developed for treatment of inflammasome-and IL-1b-induced diseases. 40 As c-FLIP is upregulated in many tumor cells and is an important target for cancer therapy, small molecule drugs that inhibit the expression of c-FLIP or induce the degradation of c-FLIP have been developed, in addition to c-FLIP-specific siRNA. 41 The present studies suggest a possibility that c-FLIP-downregulating compounds may be 
Materials and Methods
Reagents. Purified LPS, R848, HKLM, Pam3CSK4, nigericin, alum crystals, HKCA, and monosodium urate (MSU) were purchased from InvivoGen (San Diego, CA, USA). Anti-ASC (AL177), anti-NLRP3 (Cryo-2), anti-human FLIP (NF-6), and anti-mouse FLIP (Dave-2) antibodies were obtained from ENZO Life Sciences (Farmingdale, NY, USA). Anti-mouse caspase-1 (M20), anti-human caspase-1 (A19), anti-c-FLIP (H-150 and G-11) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-mature IL-1b (Asp116) and anti-Myc (9B11) antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). AT-406 was synthesized according to Cai et al. 42 Crude LPS, PMA, Flag-M2 antibodies, and Flag-M2 beads were purchased from Sigma-Aldrich (St. Louis, MO, USA). For ELISA assays, human IL-1b DuoSet, human TNF-a DuoSet, murine IL-1b DuoSet, and murine TNF-a DuoSet were obtained from R&D (Minneapolis, MN, USA).
Mice. c-FLIP
f/f mouse was previously described. 8 c-FLIP f/f mice were bred with LysMCre mice 43 (The Jackson Laboratory, Bar Harbor, ME, USA) to generate c-FLIP f/f LysMCre mice. Previous studies have shown that macrophage cannot mice. c-FLIP f/ þ mice were bred with E2A-Cre mice, followed by back-crossing to c-FLIP f/f mice to select for c-FLIP f/ À mice without E2A-Cre. PCR primers used for genomic DNA typing were FLIPSAF1, CATGAGCACTGAGGGACACAGCAC; FLIPFlox, CGGAGTTTGCTACAGGAAGGCCAC (generated 480 bp PCR product with FLIPSAF1); FLIPd, AGGCTAGTTAACTGGCTCAGC (generated 800 bp PCR product with FLIPSAF1). All mouse experiments were conducted with approval from the Institutional Animal Care and Utilization Committee, Academia Sinica.
Cell culture. Human monocyte cell line THP-1 was cultured in RPMI1640 medium supplemented with 10% fetal bovine serum (Life TechnologiesInvitrogen, Carlsbad, CA, USA), 10 mM glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin, and 20 mM 2-ME (complete RPMI medium). Bone marrow cells were collected from tibias and femurs by flushing with cold PBS with a 25G needle. Bone marrow cells were cultured either in complete DMEM medium (same supplements as complete RPMI) with 20% L929 conditioned media for 6 days to generate BMDMs, or in DMEM containing 20 ng/ml GM-CSF (R&D) for 8 days to generate BMDCs. Measurement of IL-1b. THP-1 cells were treated with 0.5 mg/ml phorbol myristate acetate (PMA) for 3 h, replenished with complete RPMI medium for overnight culture. Cells were activated by R837 (10 mg/ml), R848 (2 mg/ml), Pam3CSK4 (0.5 mg/ml), MSU (150 mg/ml), alum crystal (0.5 mg/ml), HKLM (3 Â 10 8 /ml), nigericin (10 mM), or crude LPS (15 mg/ml) in serum-free RPMI for 6 h. Both cells and culture supernatants were harvested. The contents of IL-1b or TNF-a supernatants were quantitated by ELISA. The remaining culture supernatants were precipitated by cold acetone ( À 20 1C). Both total cell lysates and supernatant precipitates were resolved by 4-20% gradient SDS-PAGE and analyzed for pro-IL-1b, IL-1b, NLRP3, procaspase-1, and caspase-1 by immunoblots. For BMDMs, cells were primed by purified LPS (0.2 mg/ml), R848 (2 mg/ml), or Pam3CSK4 (2 mg/ml) for 4 h, and the culture supernatants were collected and analyzed for TNF-a secretion. Cells were then activated by ATP (5 mM) or nigericin (10-20 mM) for 45 min or MSU (150 mg/ml) for 6 h. Both cells and culture supernatants were isolated, and analyzed by immunoblots as described for THP-1 cells.
Cell viability assay. Cell viability was determined by measuring ATP levels. LPS-primed BMDMs were treated with MSU or alum for 3 h. Equal volume of Cell Titer-Glo reagent (Promega, Madison, WI, USA) was then added and incubated for an additional 30 min. Luminescent signal was determined using a luminescence reader, the Victor3 1420 Multilabel Counter (PerkinElmer, Shelton, CT, USA).
NLRP3 inflammasome reconstitution. 293T cells were infected with recombinant lentivirus pLL3.7 or pLL3.7-shFLIP, and GFP-expressing cells were sorted 48 h post-infection. Control and pLL-shFLIP 293T cells were then transfected with pcDNA4-pro-IL-1b, pcDNA4-NLRP3-Myc, pcDNA4-ASC, and pcDNA4-procaspase-1-Myc using Lipofectamine 2000 (Invitrogen). Both cells and the culture supernatants were collected 48 h later, and analyzed by ELISA and immunoblots as described for THP-1 and BMDMs.
Pyroptosome. THP-1 cells were treated with PMA for 3 h, washed and incubated overnight. Cells were stimulated with crude LPS (5 mg/ml) or Pam3Csk4 (1 mg/ml) for 2 h, harvested and lysed in buffer A (20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 320 mM sucrose). The bulk nuclei were removed by centrifugation, after which the supernatant was diluted with equal volume of buffer A and filtered. The filtrate was diluted with an equal volume of CHAPS buffer (20 mM HEPES (pH 7.5), 5 mM MgCl 2 , 0.5 mM EGTA, 0.1 mM PMSF, 0.1% CHAPS) and centrifuged; the resulting pellet contained the ASC pyroptosomes. The pellets were resuspended in CHAPS buffer and then subjected to crosslinking using disuccinimidyl suberate (DSS) (2 mM) for 30 min. The pyroptosomes were resolved on 10% SDS-PAGE, and the levels of ASC and caspase-1 analyzed. The formation of pyroptosomes was also analyzed in ASC-mCherry-expressing THP-1 cells according to published method. 24 The ASC pyroptosomes images were acquired in Olympus (Tokyo, Japan) 1 Â 71 fluorescence microscope and Zeiss (Oberkochen, Germany) LSM 510 confocal laser scanning.
In situ proximity ligation assay. In situ proximity ligation assay was performed according to Söderberg et al. 25 using the Duolink Proximity Ligation in situ reagent kit (Olink, Uppsala, Sweden). The detailed procedures were recently described. 46 The cells were examined under a Zeiss LSM 510 confocal laser scanning microscope with a Â 63 objective lens.
NLRP3 mitochondrial localization. NLRP3 mitochondrial localization was performed as described. 26 293T cells were stained with Mitotracker Red (Invitrogen) followed by permeabilization and fixation. Cells were then sequentially stained with anti-HA (for NLRP3-HA) and Alexa Fluro-conjugated anti-mouse. Images were acquired on a Zeiss LSM 510 confocal laser scanning microscope. The colocalization of NLRP3-HA and Mitotracker was quantitated using ZEN imaging software ZEN 2010 version 6.0. Each group contains at least 10 cells. 
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